MetaCap

Biote (BTMD) vs Niagen Bioscience (NAGE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Biote (BTMD) has outperformed Niagen Bioscience (NAGE) over the past year, losing 68.9% versus a loss of 73.3%. Over five years, NAGE leads with a -62.5% price change compared with -91.6% for BTMD. Niagen Bioscience is the larger company by market cap ($145.7 million vs $26.3 million), about 5.5 times the size.

Biote converts more of its revenue into profit, with a net margin of 14.1% versus 13.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BTMD-68.90%NAGE-73.26%
+13%-32%-77%
Nov 21, 20251 yearNov 20, 2026
BTMD-91.64%NAGE-65.86%
+177%+36%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BTMD versus NAGE key metrics
MetricBTMDNAGE
Share price$0.8147$1.84
Market cap$26.28M$145.72M
1-day change-3.56%-1.60%
YTD return-68.67%-71.07%
1-year return-68.90%-73.26%
5-year return-91.64%-62.53%
P/E ratio (TTM)—15.33
Forward P/E3.33—
EPS (TTM)$-0.07$0.12
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$192.22M$129.42M
Revenue growth (YoY)-2.52%+29.95%
Net income (latest FY)$27.05M$17.38M
Gross margin71.46%64.28%
Operating margin18.50%12.58%
Net margin14.07%13.43%
52-week high$2.90$7.11
52-week low$0.81$1.79
Distance from 52-week high-71.91%-74.12%
Analyst consensusnonestrong_buy
Avg. price target upside+220.36%+479.89%
Average volume146.21K522.66K
Shares outstanding27.04M79.20M
Employees223117
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Niagen Bioscience is about 5.5 times larger than Biote by market value ($145.72M vs $26.28M).
  • Niagen Bioscience grew revenue faster in its latest fiscal year (+29.95% vs -2.52%).

About Biote

BTMD stock →

biote Corp. operates in practice-building business within the hormone optimization space.

Health Care · Medicinal Chemicals and Botanical Products · 223 employees

About Niagen Bioscience

NAGE stock →

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.

Health Care · Medicinal Chemicals and Botanical Products · 117 employees

BTMD vs NAGE FAQ

Which is bigger, Biote or Niagen Bioscience?

Niagen Bioscience (NAGE) is larger, with a market capitalization of $145.72M compared with $26.28M for Biote (BTMD).

Which stock has performed better over the past year, BTMD or NAGE?

BTMD returned -68.90% over the past 12 months, compared with -73.26% for NAGE (price return, excluding dividends). Past performance does not predict future results.

Are Biote and Niagen Bioscience in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons